Luminex, Bio-Rad Extend Deal, Includes Magpix System | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex today announced the expansion of a global sales and distribution deal with Bio-Rad Laboratories to 2023 as well as the granting of the global sales and distribution rights for the Magpix multiplexing platform.

Under the terms of the agreement Bio-Rad will offer Luminex's xMAP systems, including the Magpix system, which detects up to 50 different analytes on a single sample.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.